PHARMACY

Hikma gets FDA nod for generic Victoza, launches 2 new generics
Generic Victoza is a GLP-1 receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 years and older with Type 2 diabetes as an adjunct to diet and exercise.
The Compliance Team to host 2025 Drug Supply Chain Security Act webinar
The webinar will take place on Jan. 9 from 2:00-3:00 P.M. ET.

FDA approves Celltrion's Stelara biosimilar

Steqeyma is approved for adult and pediatric patients with plaque psoriasis and active psoriatic arthritis as well as adults with Crohn's disease and ulcerative colitis.
What healthcare technology trends will play out in 2025?

A Wolters Kluwer Health prediction report features 25 wide-ranging predictions spanning health AI, preventing burnout, tech for the next generation and more.
Lupin receives FDA nod for generic Descovy

The drug is indicated for the treatment of HIV-1 infection and for pre-exposure prophylaxis to reduce the risk of HIV-1 infection in adults and adolescents.
Wisp partners with Nourish to offer patients on GLP-1s personalized nutrition counseling

Wisp patients can now access nutrition counseling services either through their health insurance or a self-pay rate.
Camber debuts generic Tarceva

Erlotinib tablets are a kinase inhibitor indicated for the treatment of patients with certain types of cancer.
GoodRx names Wendy Barnes president and CEO

Barnes will focus on advancing GoodRx’s strategic initiatives, per the company.
Dexcom debuts GenAI platform in glucose biosensing

The Dexcom GenAI platform analyzes individual health data patterns to reveal a direct association between lifestyle choices and glucose levels.
Pharmacy groups to “key vote” continuing resolution with PBM reforms

Voting “Yes” on a continuing resolution with specific Medicaid and Medicare reforms is essential to confront PBM tactics that inflate American’s prescription drug costs, the pharmacy groups said.